| __timestamp | Dr. Reddy's Laboratories Limited | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 1595000 |
| Thursday, January 1, 2015 | 17449000000 | 11434000 |
| Friday, January 1, 2016 | 17834000000 | 26546000 |
| Sunday, January 1, 2017 | 19551000000 | 39778000 |
| Monday, January 1, 2018 | 18265000000 | 53418000 |
| Tuesday, January 1, 2019 | 15607000000 | 111997000 |
| Wednesday, January 1, 2020 | 15410000000 | 139507000 |
| Friday, January 1, 2021 | 16541000000 | 195958000 |
| Saturday, January 1, 2022 | 17482000000 | 248149000 |
| Sunday, January 1, 2023 | 19381000000 | 232366000 |
| Monday, January 1, 2024 | 22873000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Dr. Reddy's Laboratories Limited, a major player in the pharmaceutical industry, has consistently outpaced ImmunityBio, Inc. in R&D investments over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories increased its R&D spending by approximately 85%, peaking in 2024 with a projected 30% rise from the previous year. In contrast, ImmunityBio's R&D expenses, while growing, remain a fraction of Dr. Reddy's, highlighting a strategic difference in resource allocation. The data reveals a stark contrast in financial commitment to innovation, with Dr. Reddy's investing nearly 100 times more than ImmunityBio in 2023. This disparity underscores the varying approaches to R&D in the pharmaceutical and biotech sectors, with potential implications for future market positioning and product development.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Biogen Inc. and ImmunityBio, Inc. Allocate Funds
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited